Skip to main content

Advertisement

Log in

Comments on the letter of Galland et al. on “A rare cause of AA amyloidosis and end-stage kidney failure”

  • Letter to the Editors
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Durel CA, Aouba A, Bienvenu B et al (2016) Observational study of a French and Belgian multicenter cohort of 23 patients diagnosed in adulthood with mevalonate kinase deficiency. Medicine (United States). https://doi.org/10.1097/MD.0000000000003027

  2. Van Der Hilst JCH, Bodar EJ, Barron KS et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). https://doi.org/10.1097/MD.0b013e318190cfb7

  3. Obici L, Manno C, Muda AO et al (2004) First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum. https://doi.org/10.1002/art.20490

  4. Schlabe S, Schwarze-Zander C, Lohse P, Rockstroh JK (2016) Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever. BMJ Case Rep. https://doi.org/10.1136/bcr-2016-217616

  5. Miray Kisla Ekinci R, Balcı S, Bisgin A et al (2019) Hyperimmunoglobulinemia D syndrome with recurrent perianal abscess successfully treated with canakinumab. Scott Med J. https://doi.org/10.1177/0036933019836405

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Taşdemir.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taşdemir, M., Yılmaz, S., Baba, Z.F. et al. Comments on the letter of Galland et al. on “A rare cause of AA amyloidosis and end-stage kidney failure”. Pediatr Nephrol 34, 1633–1634 (2019). https://doi.org/10.1007/s00467-019-04277-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-019-04277-9

Navigation